Zobrazeno 1 - 10
of 59
pro vyhledávání: '"LUCIE BROZOVA"'
Autor:
Jiri Minarik, Tomas Pika, Jakub Radocha, Alexandra Jungova, Jan Straub, Tomas Jelinek, Ludek Pour, Petr Pavlicek, Martin Mistrik, Lucie Brozova, Petra Krhovska, Katerina Machalkova, Pavel Jindra, Ivan Spicka, Hana Plonkova, Martin Stork, Jaroslav Bacovsky, Lenka Capkova, Michal Sykora, Petr Kessler, Lukas Stejskal, Adriana Heindorfer, Jana Ullrychova, Tomas Skacel, Vladimir Maisnar, Roman Hajek
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-13 (2021)
Abstract Background We have performed a head to head comparison of all-oral triplet combination of ixazomib, lenalidomide and dexamethasone (IRD) versus lenalidomide and dexamethasone (RD) in patients with relapsed and refractory multiple myeloma (RR
Externí odkaz:
https://doaj.org/article/f4b149c2be57476793d1f90b53292d39
Autor:
Walter Bouwmeester, Andrew Briggs, Ben van Hout, Roman Hájek, Sebastian Gonzalez-McQuire, Marco Campioni, Lucy DeCosta, Lucie Brozova
Publikováno v:
Oncology and Therapy, Vol 7, Iss 2, Pp 141-157 (2019)
Abstract Introduction Risk stratification tools provide valuable information to inform treatment decisions. Existing algorithms for patients with multiple myeloma (MM) were based on patients with newly diagnosed disease, and these have not been valid
Externí odkaz:
https://doaj.org/article/34de09481f8547d2af327987f0b0730d
Autor:
Jiri Minarik, Ludek Pour, Vladimir Maisnar, Ivan Spicka, Alexandra Jungova, Tomas Jelinek, Lucie Brozova, Petra Krhovska, Vlastimil Scudla, Roman Hajek
Publikováno v:
Biomedical Papers, Vol 163, Iss 3, Pp 279-283 (2019)
Objective: The treatment of relapsed and refractory multiple myeloma (RRMM) remains challenging. The outcomes in highly pretreated populations are unsatisfactory and there is urgent need for novel and safe therapeutic approaches. Recently, daratumuma
Externí odkaz:
https://doaj.org/article/ba00345e23af4c23b574b7f1d59203c2
Autor:
Zuzana Chyra, Tereza Sevcikova, Petr Vojta, Janka Puterova, Lucie Brozova, Katerina Growkova, Jana Filipova, Martina Zatopkova, Sebastian Grosicki, Agnieszka Barchnicka, Wieslaw Wiktor Jedrzejczak, Anna Waszczuk-Gajda, Alexandra Jungova, Aneta Mikulasova, Marian Hajduch, Martin Mokrejs, Ludek Pour, Martin Stork, Lubica Harvanova, Martin Mistrik, Gabor Mikala, Pawel Robak, Anna Czyz, Jakub Debski, Lidia Usnarska-Zubkiewicz, Artur Jurczyszyn, Lukas Stejskal, Gareth Morgan, Fedor Kryukov, Eva Budinska, Michal Simicek, Tomas Jelinek, Matous Hrdinka, Roman Hajek
Publikováno v:
Haematologica, Vol 106, Iss 2 (2020)
Externí odkaz:
https://doaj.org/article/8ca446e23b564678a7535e85cd1ee3ce
Autor:
Jiri Minarik, Petr Pavlicek, Ludek Pour, Tomas Pika, Vladimir Maisnar, Ivan Spicka, Jiri Jarkovsky, Marta Krejci, Jaroslav Bacovsky, Jakub Radocha, Jan Straub, Petr Kessler, Marek Wrobel, Lenka Walterova, Michal Sykora, Jarmila Obernauerova, Lucie Brozova, Evzen Gregora, Dagmar Adamova, Jaromir Gumulec, Zdenek Adam, Vlastimil Scudla, Roman Hajek, Czech Myeloma Group
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0123866 (2015)
OBJECTIVE:Subcutaneous (SC) application of bortezomib has been recently introduced as a new application route in multiple myeloma (MM) patients. We performed an analysis to compare the outcomes of bortezomib-based therapy in multiple myeloma (MM) pat
Externí odkaz:
https://doaj.org/article/781e01a2fb62439984783e51c9bbd51c
Autor:
Tomas Jelinek, Jiri Minarik, Ivan Spicka, Petra Krhovska, Viera Sandecká, Martin Stork, Ludek Pour, Jan Straub, Sabina Ševčíková, Petr Pavlicek, Alexandra Jungova, Jakub Radocha, Roman Hájek, Lucie Brozova, Jiri Jarkovsky, Vladimir Maisnar, Lenka Pospisilova
Publikováno v:
British Journal of Haematology. 196:954-962
Multiple myeloma (MM) is characterized by malignant plasma cell infiltration of the bone marrow. In extramedullary multiple myeloma (EMD), a subclone of these cells migrates out of the bone marrow. Out of 4 985 MM patients diagnosed between 2005 and
Publikováno v:
Echocardiography (Mount Kisco, N.Y.)REFERENCES. 39(9)
In stress echocardiography (SE), dipyridamole (DIP) and dynamic stress (ExSE) are reported as being safer than dobutamine stress echocardiography (DSE). We investigated whether these commonly used stressors cause myocardial injury, measured by high s
Autor:
MARTIN SVATON, MONIKA BRATOVA, LEONA KOUBKOVA, ONDREJ FISCHER, BOHUSLAV MELICHAR, MICHAL HRNCIARIK, DANIEL DOLEZAL, ONDREJ BILEK, JANA KREJCI, MARIE DROSSLEROVA, ZDENKA DLOUHA, JIRI BLAZEK, PETRA MAJKOVA, LUCIE BROZOVA, MAREK STASTNY
Publikováno v:
Anticancer research. 42(4)
This study compared the results of nivolumab treatment in patients with pulmonary adenocarcinomas based upon previous chemotherapeutic regimens.The data source for this retrospective study was the Czech VILP registry of patients with nivolumab-treate
Publikováno v:
Proceedings of the 16th Economics & Finance Conference, Prague.
Autor:
Ben van Hout, Lucy DeCosta, Walter Bouwmeester, Marco Campioni, Sebastian Gonzalez-McQuire, Roman Hájek, Lucie Brozova, Andrew Briggs
Publikováno v:
Oncology and Therapy
Oncology and Therapy, Vol 7, Iss 2, Pp 141-157 (2019)
Oncology and Therapy, Vol 7, Iss 2, Pp 141-157 (2019)
Introduction Risk stratification tools provide valuable information to inform treatment decisions. Existing algorithms for patients with multiple myeloma (MM) were based on patients with newly diagnosed disease, and these have not been validated in t